Pazufloxacin
- Level
- Commodity
- Parent
- 51282900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282936This classification denotes a quinolone antibiotic with the molecular formula C16H15FN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4CZ1R38NDI, chemically known as 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-, (s)- but generally known as pazufloxacin, which bears US NIH Compound Identifier 65957. European Medicines Agency schedules Pazufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09641MIG. The term PAZUFLOXACIN is an International Non-Proprietary Name. World Health Organization schedules pazufloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. PAZUFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pazufloxacin under HS 29349990 and SITC 51579. As of Q4 2014, PAZUFLOXACIN remains the US FDA Preferred Term for this commodity. Pazufloxacin bears US NLM identifiers UMLS ID C0175022 and NCI Concept Code C66331. SMILES: FC1C(C2(N)CC2)C2OCC(N3C2C(C1)C(=O)C(C3)C(=O)O)C.
Same parent
Under 51282900 · 57Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.